Engflag

Termedol

Quick links to important sections

Termedol

Termedol_EN

Method of action: Bactericidal, Bactericidal Broad Spectrum, Ophthalmologicals

Treatment option: Bacterial Conjunctivitis, Bacteremia, Bronchitis, Community Acquired Pneumonia, Influenza, Infection, Pneumonia, Prostatitis, Pink Eye, Tuberculosis

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Termedol

Termedol is a synthetic, prescription-only medication whose core function is to combat bacterial infections by using the potent active ingredient Levofloxacin.

Quick Facts: Termedol

Property Description
Active ingredient Levofloxacin (S-(-) isomer)
Form Oral tablets, oral solution, intravenous (IV) solution
Pharmacological class Fluoroquinolone Antibiotic (Third Generation)
Common use Treatment of bacterial infections
Origin Synthetic compound

What Type of Medicine is Termedol? (Identity and Classification)

Termedol is categorized as a third-generation fluoroquinolone antibiotic, a powerful class of anti-infective agents reserved for treating susceptible bacterial infections. The therapeutic effect stems solely from its single active component, Levofloxacin, which is the purified, active S-(-) isomer of the older antibiotic, Ofloxacin. The drug’s action is inherently bactericidal, actively killing the microbes rather than merely stopping their growth.

This pharmacological classification is known for its broad-spectrum efficacy against a wide range of bacteria. The efficacy of this L-isomer against various organisms makes it a critical tool in antibiotic support.

Termedol Composition and Available Forms (Presentation and Delivery)

Termedol is typically offered as oral tablets and an oral solution for use by mouth, as well as a sterile intravenous (IV) solution for parenteral administration in hospital settings. The medication is available in both oral and intravenous preparations.

This dual-route availability is clinically recognized for facilitating a seamless transition from initial IV treatment in a hospital to continued oral therapy at home. The formulation is a single-ingredient product, consisting of Levofloxacin combined with inert excipients for the solid tablet form or a sterile aqueous vehicle for the liquid preparations.

What is the General Purpose of Termedol? (Fundamental Action and Benefit)

The overall purpose of Termedol is to provide definitive treatment for infections caused by susceptible bacteria throughout the body. The medication is designed to fight bacterial illness by eliminating the causative microbes at the source.

The resulting benefit is the resolution of the infection, which is achieved through the drug's powerful bactericidal action and its ability to penetrate various bodily tissues. Levofloxacin is recognized as an essential medicine, signifying that the medication is considered one of the most effective and safe medicines needed in a health system.

Regulatory References

  1. WHO Essential Medicines List for Levofloxacin

What side effects are possible with Termedol?

Possible side effects and safety information

The safety profile of Termedol, which contains the active ingredient Levofloxacin, is defined by documented adverse reactions and specific systemic warnings associated with the fluoroquinolone antibiotic class. Official regulatory documentation classifies the potential for serious, disabling, and potentially irreversible reactions affecting multiple body systems, which is a primary safety focus.

Officially Documented Adverse Reactions

The most common adverse reactions, as documented in clinical trial data (ge 3% incidence), include nausea, headache, diarrhea, insomnia, constipation, and dizziness.

Adverse reactions are also grouped by the physiological systems involved, known as System-Organ Classes. These include the Musculoskeletal and Connective Tissue, Nervous System, Psychiatric Disorders, Cardiac Disorders, and Hepatobiliary System.

Serious and Systemic Safety Concerns

The most significant safety concerns are those designated as serious adverse reactions, which can be disabling and potentially irreversible.

System Affected Serious Reaction Type (as documented in regulatory sources)
Musculoskeletal Tendinitis and Tendon Rupture (may occur within 48 hours or months after cessation)
Nervous/Sensory Peripheral Neuropathy (sensory or sensorimotor)
Cardiovascular QT Interval Prolongation, Torsade de Pointes, and Aortic Aneurysm/Dissection
Hepatobiliary Severe, potentially fatal Hepatotoxicity

Population-Specific Safety Notes

The regulatory label specifies that certain populations have an increased risk. Older adults are more susceptible to tendon disorders and cardiac issues (QT prolongation). Patients with renal impairment face an increased risk of adverse reactions due to drug clearance. Pediatric patients have documented occurrences of musculoskeletal disorders, including arthralgia and gait abnormality. Safety constraints also restrict use in individuals with a history of epilepsy or a prior serious adverse reaction to any quinolone drug.

Overdose and Emergency Response

Termedol Overdose and When to Seek Help

Regulatory information specifies that an overdose of Termedol (Levofloxacin) is characterized by documented Central Nervous System (CNS) effects such as dizziness, confusion, and tremors. These signs can escalate to severe manifestations, including convulsions and coma. Gastrointestinal disturbances, such as nausea and mucosal erosions, are also noted presentations.

The most serious documented risk involves the cardiovascular system, where excessive exposure can lead to prolongation of the QT interval and subsequent fatal arrhythmias, including Torsade de Pointes (TdP). This risk mandates immediate and continuous ECG monitoring in a hospital setting. Furthermore, elderly patients and individuals with underlying CNS disorders are noted as having an increased risk for severe neurological manifestations.

Management is strictly symptomatic and supportive, as regulatory documents state that no specific antidote is known for Levofloxacin overdose. Dialysis procedures (hemodialysis or peritoneal dialysis) are officially described as ineffective for drug elimination. Seek immediate medical attention or contact emergency services immediately upon the suspicion of an overdose or the appearance of any associated symptom.

Overdose Management Focus Official Regulatory Statement
Antidote Availability No specific antidote is known.
Required Intervention Symptomatic and supportive treatment.
Mandatory Monitoring Continuous ECG monitoring is required due to cardiac risk.
Help Seeking Seek immediate medical attention.

Therapeutic Uses of Termedol

What Termedol Treats: Main Uses and Benefits

Termedol (Levofloxacin) may be part of symptomatic management in situations where patients experience conditions presenting with systemic or localized discomfort and is applied in addressing symptoms that interfere with daily functioning. Its therapeutic purpose is relevant for easing symptoms related to physical discomfort associated with acute or episodic changes across major body systems. This therapeutic use is relevant in contexts involving heightened systemic burden due to bacterial illness, which may assist with maintaining functional stability in situations where patients experience heightened systemic burden.

The medication is considered relevant in contexts involving heightened systemic burden, generally supporting the patient during difficult episodes by easing distress. The conditions addressed include Community-Acquired Pneumonia and acute bacterial exacerbation of chronic bronchitis, infections of the urinary and renal tracts (Acute Pyelonephritis), skin and soft-tissue infections, and post-exposure prophylaxis for Anthrax. It may assist with managing symptoms related to inflammatory or irritative states, such as severe localized swelling and tenderness.

“Applied in clinical settings that involve acute or unstable symptom patterns, it helps address symptom clusters that may become intense or disruptive, contributing to improved comfort during periods of heightened symptoms.”

Quick Fact: Support for Symptom Burdens

Termedol contributes to improved comfort by managing the underlying infection, which may assist with managing symptoms related to systemic imbalance like high fever and noticeable physiological strain such as respiratory distress or localized pain.

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Termedol — official regulatory information

Termedol (Levofloxacin) is a fluoroquinolone antibiotic with specific restrictions defined in official regulatory documents. Its use is permitted in adults (18 years and older), but is largely prohibited or conditional in other populations.

Category Official Regulatory Status/Statement
Populations for whom use is allowed Adults (18 years and older). Pediatric patients geq 6 months old for Anthrax and Plague only.
Populations for whom use is contraindicated Patients with known hypersensitivity to Levofloxacin or any other quinolone antibacterial agent.
Patients with epilepsy or a history of tendon disorders related to previous fluoroquinolone use.
Age-related eligibility rules Contraindicated in children and growing adolescents for most indications. Safety is not established in children younger than six months of age.
Pregnancy and lactation eligibility Contraindicated during pregnancy and in breast-feeding women.
Condition-specific eligibility rules Patients with renal impairment require mandatory dose adjustment. Use should be avoided in patients with a history of Myasthenia Gravis.
Eligibility-related restrictions Caution is required for older patients (geq 60 years), solid organ transplant recipients, and patients with known risk factors for QT interval prolongation.

The official labeling defines who can and cannot use the medicine through a framework of absolute contraindications and numerous restricted-use populations. These restrictions are based on known risks associated with the drug class, including pre-existing neurological, cardiac, and musculoskeletal conditions. Use is strictly limited to adults and specific pediatric cases while requiring mandatory dose adjustments for patients with impaired kidney function, as explicitly stated in the regulatory documentation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Termedol's interaction profile is defined by both pharmacokinetic (drug metabolism) and pharmacodynamic (additive effects) mechanisms, as documented in regulatory information. Co-administration with certain drug classes may require dose adjustment or be contraindicated.

Contraindicated and High-Risk Combinations

Concomitant use with Monoamine Oxidase Inhibitors (MAOIs) is strictly contraindicated. A minimum 14-day washout period is required after discontinuing an MAOI before initiating Termedol, and vice versa. This combination carries a risk of severe adverse outcomes due to additive effects.

Clinically Significant Interactions

The co-administration of Termedol with other serotonergic drugs (e.g., SSRIs, SNRIs, triptans) may significantly increase the risk of Serotonin Syndrome. Caution and close monitoring are mandatory if these combinations are deemed necessary.

Furthermore, using Termedol with other Central Nervous System (CNS) depressants (e.g., opioids, alcohol, sedatives, anxiolytics) increases the potential for profound sedation and respiratory depression. Patients are typically advised to avoid or severely limit the use of these substances together.

Metabolic Interactions

Inhibitors of CYP3A4 and/or CYP2D6 (e.g., certain antibiotics, antifungals) can increase the plasma concentrations of Termedol or its active metabolite, potentially increasing the risk of adverse effects. Conversely, co-administration with strong CYP3A4 inducers (e.g., rifampin, carbamazepine) may decrease Termedol's concentration, leading to reduced efficacy. Close clinical observation is required when initiating or discontinuing these interacting medicines.

Mechanism of Action

Termedol functions through a bactericidal mechanism by directly disrupting the core genetic machinery of susceptible bacteria. Its action focuses on two interconnected mechanistic domains, triggering a cascade that culminates in the death of the microbial cell.

The initial molecular interaction involves the drug acting as an inhibitor against two essential bacterial enzymes: DNA gyrase and topoisomerase IV. By binding to the enzyme-DNA complex, the molecule prevents the enzymes from properly managing the physical structure and winding of the bacterial chromosome, initiating the lethal cascade.

The resulting physiological consequences stem from this enzyme inhibition. The molecule causes a buildup of double-stranded DNA breaks that overwhelm the cell's repair mechanisms and physically prevents the final stage of cell division. This sustained genetic and physical insult leads to bacterial cell lysis and elimination, the ultimate physiological change that results from the mechanism.

Dosage and Administration Information

How to use Termedol — General Administration Guidelines

Termedol (immediate-release formulation) is for oral administration and must be used strictly as directed to mitigate risks and ensure proper effect.

Administration Detail Guidelines
Preparation Tablets and capsules must be swallowed whole (intact). Do not cut, break, chew, crush, or dissolve them.
Timing May be taken with or without food. Take the dose at about the same time each day if on a fixed schedule.
General Dosing Treatment must begin with the lowest effective dosage for the shortest duration consistent with treatment goals. The total daily dose should generally not exceed 400 mg/day.
Initial Titration Start at 25 mg/day and increase in 25 mg increments every 3 days to reach 100 mg/day (25 mg four times a day). Subsequent increases may be 50 mg every 3 days up to 200 mg/day.
Aged Patients For patients over 75 years old, the maximum daily dose should not exceed 300 mg/day.
Organ Impairment For severe renal impairment (creatinine clearance less than 30 mL/min), the dosing interval should be increased to 12 hours, with a maximum daily dose limited to 200 mg. For severe hepatic impairment, the recommended dose is 50 mg every 12 hours.
Missed Dose If a dose is missed, take it as soon as you remember, unless it is almost time for the next scheduled dose. Never take two doses at the same time to make up for a missed one.
Discontinuation The drug should not be abruptly discontinued in physically dependent patients; the dose must be tapered gradually to prevent serious withdrawal symptoms.

All patients must adhere to the prescribed regimen, as the individual dose is based on the patient's pain severity and prior analgesic experience.

Recent Clinical Evidence

Termedol: Recent Clinical Evidence

Evidence Supporting Research on Lung and Airway Infections

Termedol was evaluated in research exploring Community-Acquired Pneumonia (CAP), a condition related to the lungs. Research relied on Randomized Controlled Trials (RCTs), comparing the medicine against other study treatments or durations. These studies focused on measuring outcomes related to symptom evolution (like fever and cough), the microbial status (related to bacterial counts), and tracking outcomes related to Hospitalization Length of Stay. Studies reported patterns observed in the populations related to clinical symptom evolution. What remains uncertain is the need for more information on the long-term status of patients; Follow-up durations were limited to the short treatment period and about 30 days.

Evidence Supporting Research on Urinary and Kidney Tract Infections

Termedol was evaluated in research exploring Complicated Urinary Tract Infections (cUTI) and Acute Pyelonephritis (kidney infections). The research includes Randomized Controlled Trials and Systematic Reviews comparing it to other study treatments. Researchers examined outcomes related to physical discomfort and signs of infection, measuring outcomes linked to symptom improvement and outcomes related to microbial load. Comparative evidence describes patterns related to the microbiological status of the organisms post-treatment. Evidence highlights an acknowledged gap regarding the long-term impact of increasing global antibiotic resistance on this medicine’s future utility for these conditions.

Research Gaps and Special Populations

Research has explored Pediatric Patients (children) for certain indications, but evidence is limited and does not fully characterize the experience in this group compared to adults. In research populations, individuals with severe renal impairment were often excluded from the main trials, indicating that the results apply only to the populations studied, and data for certain groups remain insufficient. While existing research provides context, it does not determine whether an individual will respond similarly, as study results reflect group patterns, not personal outcomes.

Key Studies & References

  1. Levofloxacin Prescribing Information and FDA-Approved Indications
  2. Levofloxacin Versus Ciprofloxacin in the Treatment of Urinary Tract Infections: Evidence-Based Analysis
  3. Fluoroquinolones for the Management of Skin and Soft Tissue Infections (Review of evidence for high-dose levofloxacin)
  4. Respiratory fluoroquinolones for the treatment of community-acquired pneumonia: a meta-analysis of randomized controlled trials

Frequently Asked Questions (FAQ)

Common questions about Termedol (FAQ)

Q: Who should not take this medicine (contraindications)?

A: Official regulatory documents state that Termedol is contraindicated (not recommended for use) for individuals with a known hypersensitivity. This indicates that the medicine is typically not used if a patient has a severe allergic reaction to the active substance (pregabalin) or any other components (excipients) in the product.

Q: Does this medicine make you sleepy or affect your concentration?

A: Yes, regulatory information indicates that this medicine may cause common central nervous system effects such as dizziness and somnolence (drowsiness). Due to these potential effects, label information states that this medicine may impair the ability to drive, operate machinery, or perform tasks that require high levels of concentration or attention.

Q: Can I take this medicine with ibuprofen?

A: Regulatory studies evaluating potential drug interactions have not identified any direct pharmacokinetic interactions between Termedol and ibuprofen. Since interactions can be complex, it is important for patients to discuss all medicines they are taking, including non-prescription products like ibuprofen, with their healthcare provider.

Q: Can children 2 years old use this medicine?

A: According to the official product information, the safety and effectiveness of Termedol have not been established in children under 12 years of age. For the approved uses, use is typically restricted because safety and effectiveness information is lacking for this younger age group.

How should Termedol be stored and disposed of?

How to Store and Dispose of Termedol?

Termedol must be stored according to regulatory requirements to ensure its quality and effectiveness are maintained.

Storage Requirements

Condition Requirement
Temperature Store below 25 C (Controlled Room Temperature).
Handling Do not refrigerate or freeze; protect from frost.
Light/Moisture Keep in the original container and store in the outer carton to protect from light.

Disposal Instructions

Unused or expired Termedol must be disposed of properly. Do not dispose of this medicine in household trash or down a drain unless specifically instructed by official guidelines, such as the FDA's flush list. Follow official local, state, and federal guidelines for the disposal of unused medicine, often utilizing drug take-back programs at pharmacies or police stations to minimize environmental impact and accidental ingestion.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagColombia

Equivalent of Termedol found in:

A-Z Index: